ARTV – artiva biotherapeutics, inc. (US:NASDAQ)
Stock Stats
News
Artiva Biotherapeutics (ARTV) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $18.00 price target on the stock.
Artiva Biotherapeutics GAAP EPS of -$3.43 [Seeking Alpha]
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
Artiva Biotherapeutics Pivots to Rheumatoid Arthritis at TD Cowen, Teases 2026 RA Data Update [Yahoo! Finance]
Form 4 Artiva Biotherapeutics, For: Mar 10 Filed by: Huston Thad Allen
Form S-8 Artiva Biotherapeutics,
Form 10-K Artiva Biotherapeutics, For: Dec 31
Form 8-K Artiva Biotherapeutics, For: Mar 10
Form 3 Artiva Biotherapeutics, For: Feb 18 Filed by: Huston Thad Allen
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.